Physician profile
Gregory Heiser
NPI 1053763672
$210.83
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $13.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $54.12 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $50.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.41 | 2021 | |
| Novo Nordisk INC | $13.92 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.84 | 2021 | |
| Daiichi Sankyo INC. | $13.32 | 2021 | |
| Glaxosmithkline, LLC. | $13.12 | 2022 | |
| Abbvie INC. | $11.90 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $11.73 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.07 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Heiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.